- $76.70bn
- $77.17bn
- $10.85bn
- 81
- 40
- 82
- 76
Annual cashflow statement for CME, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
R2019 December 31st | R2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | 2,116 | 2,106 | 2,637 | 2,691 | 3,226 |
| Depreciation | |||||
| Amortisation | |||||
| Deferred Taxes | |||||
| Non-Cash Items | 110 | 119 | -497 | 79.5 | 10.8 |
| Unusual Items | |||||
| Equity in Net Earnings/Losses | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | -22.7 | 67.8 | -157 | -53.9 | -60.8 |
| Change in Accounts Receivable | |||||
| Change in Other Assets | |||||
| Change in Accounts Payable | |||||
| Change in Taxes Payable | |||||
| Change in Other Liabilities | |||||
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | 2,673 | 2,716 | 2,402 | 3,056 | 3,454 |
| Capital Expenditures | -246 | -198 | -127 | -89.7 | -76.4 |
| Purchase of Fixed Assets | |||||
| Other Investing Cash Flow Items | 93 | 22 | 186 | -400 | 97.3 |
| Sale of Business | |||||
| Sale of Fixed Assets | |||||
| Sale/Maturity of Investment | |||||
| Purchase of Investments | |||||
| Cash from Investing Activities | -153 | -176 | 58.4 | -490 | 20.9 |
| Financing Cash Flow Items | -2,362 | 49,661 | 71,133 | -22,733 | -45,087 |
| Other Financing Cash Flow | |||||
| Total Cash Dividends Paid | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | -4,719 | 47,247 | 69,909 | -25,382 | -48,339 |
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | -2,199 | 49,787 | 72,370 | -22,816 | -44,865 |